Regular screening for female cancers is crucial for early detection and better outcomes. Monitoring key health markers allows for early intervention and helps track changes in your health over time. The Female Cancer Screening package includes tests like Alpha Feto Protein (AFP), CA 125, CA 15.3, CA 19.9, Carcino Embryonic Antigen (CEA), and Beta HCG Quantitative, which help detect potential signs of various cancers. By staying on top of these markers, you can take proactive steps toward maintaining your health and addressing any concerns promptly.